ArticleLeukemia2021

miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia.

Thi Thanh Vu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.